Zdrowie i gospodarka · 26/09/2016
FDA Announces Public Meeting to Discuss Generic Drug User Fee Reauthorization
The FDA is hosting a public meeting to gather feedback on proposed recommendations for reauthorizing the Generic Drug User Fee Amendments of 2012, which authorize the collection of fees for generic drug reviews and inspections, set to expire at the end of September 2017.